Trademark: 87875067
Word
CRINETICS PHARMACEUTICALS
Status Date
Tuesday, December 28, 2021
Registration Number
6603347
Registration Date
Tuesday, December 28, 2021
Filing Date
Thursday, April 12, 2018
Published for Opposition
Tuesday, September 18, 2018
42 Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others
The mark consists of the word "CRINETICS" above the word "PHARMACEUTICALS" with a dot and line spirograph design in the shape of a half circle starting above the letter "I" in "CRINETICS" and wrapping around the first letter "C" in "CRINETICS".
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"
Feb 28, 2024
Teas Change Of Correspondence Received
Feb 28, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 28, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 28, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 28, 2024
Teas Change Of Owner Address Received
Dec 28, 2021
Registered-Principal Register
Nov 20, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 19, 2021
Allowed Principal Register - Sou Accepted
Nov 2, 2021
Statement Of Use Processing Complete
Oct 29, 2021
Use Amendment Filed
Oct 29, 2021
Teas Statement Of Use Received
May 8, 2021
Notice Of Approval Of Extension Request E-Mailed
May 7, 2021
Sou Extension 5 Granted
Apr 29, 2021
Sou Extension 5 Filed
May 7, 2021
Case Assigned To Intent To Use Paralegal
Apr 29, 2021
Sou Teas Extension Received
Oct 30, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 28, 2020
Sou Extension 4 Granted
Oct 28, 2020
Sou Extension 4 Filed
Oct 28, 2020
Sou Teas Extension Received
Apr 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 24, 2020
Sou Extension 3 Granted
Apr 24, 2020
Sou Extension 3 Filed
Apr 24, 2020
Sou Teas Extension Received
Oct 23, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 21, 2019
Sou Extension 2 Granted
Oct 21, 2019
Sou Extension 2 Filed
Oct 21, 2019
Sou Teas Extension Received
Apr 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2019
Sou Extension 1 Granted
Apr 17, 2019
Sou Extension 1 Filed
Apr 17, 2019
Sou Teas Extension Received
Apr 17, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 17, 2019
Teas Change Of Owner Address Received
Nov 13, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 18, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 18, 2018
Published For Opposition
Aug 29, 2018
Notification Of Notice Of Publication E-Mailed
Aug 16, 2018
Assigned To Lie
Aug 6, 2018
Approved For Pub - Principal Register
Aug 6, 2018
Examiner's Amendment Entered
Aug 6, 2018
Notification Of Examiners Amendment E-Mailed
Aug 6, 2018
Examiners Amendment E-Mailed
Aug 6, 2018
Examiners Amendment -Written
Jul 31, 2018
Assigned To Examiner
Apr 24, 2018
Notice Of Design Search Code E-Mailed
Apr 21, 2018
New Application Office Supplied Data Entered
Apr 16, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
